Altimmune, Inc. (NASDAQ:ALT) Q2 2025 Earnings Call Transcript August 12, 2025
Altimmune, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.32.
Operator: Good morning, ladies and gentlemen, and welcome to the Altimmune Second Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. A reminder, this call is being recorded. I’ll now...
